banner
Home / News / Pharmaceutical Manufacturing Equipment Market worth $19.7 billion by 2028
News

Pharmaceutical Manufacturing Equipment Market worth $19.7 billion by 2028

Jun 14, 2023Jun 14, 2023

News provided by

18 May, 2023, 12:00 ET

Share this article

CHICAGO, May 18, 2023 /PRNewswire/ -- The Pharmaceutical Manufacturing Equipment market is expected to reach USD 19.7 billion by 2028 from USD 14.5 billion in 2023, at a CAGR of 6.3% during the 2023–2028 period according to a new report by MarketsandMarkets™. The major factors driving the market growth of the pharmaceutical manufacturing equipment market include growing potential of the pharmaceutical industry worldwide, growing necessity for adoption of flexible pharmaceutical manufacturing practices, rising need to reduce lead times, and increasing demand for generics.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=268102519

Browse in-depth TOC on "Pharmaceutical Manufacturing Equipment Market" 191 – Tables49 – Figures224 – Pages

Silicon Photonics Market Report Scope:

Report Coverage

Details

Market Revenue in 2023

$14.5 billion

Estimated Value by 2028

$19.7 billion

Growth Rate

Poised to grow at a CAGR of 6.3%

Market Size Available for

2019–2028

Forecast Period

2023–2028

Forecast Units

Value (USD Million/Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

By Equipment Type, End-Product Type, and Region

Geographies Covered

North America, Europe, Asia Pacific, and Rest of World

Key Market Challenge

Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment

Key Market Opportunities

Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages

Key Market Drivers

Rising demand for generics

Packaging machines are expected to register the highest growth and also hold the largest share of the market followed by mixing and blending machines and spray drying equipment.

Packaging machines offer a variety of applications such as cartooning, serialization, labelling, and capping, among others. Blister packaging machines accurately fill each blister with the required medication amount, seal it with foil or plastic, and cut and perforate the packaging for easy opening. Cartooning machines package products into cardboard boxes. They can also label and package the boxes for distribution. The diversity, accuracy, and efficiency of packaging machines makes them one of the most sorts after equipment in the pharmaceutical manufacturing industry to ensure effective packaging of drugs for better safety and prevention against contamination. Pharmaceutical packaging machines help to automate the packaging process, reduce errors, and increase efficiency. This leads to cost savings for pharmaceutical manufacturers, which is a significant factor in the growing demand for these machines. The pharmaceutical industry is heavily regulated, and there are strict guidelines for the packaging and labeling of pharmaceutical products. This has led to the adoption of advanced packaging machines that meet the safety and quality standards set by regulatory bodies such as the FDA. With the development of new drugs and therapies, there is a growing need for precise mixing and blending of multiple ingredients. Pharmaceutical mixing and blending machines offer the ability to homogenously mix various active pharmaceutical ingredients (APIs), excipients, and other components to ensure uniformity and consistency in the final product, thereby driving their demand.

Liquid end-product type is expected to register the highest growth and also hold the larger share of the market.

Liquid dosage forms are a type of pharmaceutical formulation that consists of a liquid medium containing one or more active pharmaceutical ingredients (APIs) and other excipients. They are used for a wide range of drugs, including antibiotics, antacids, cough syrups, and analgesics. Liquid dosage forms provide easier administration, rapid absorption, and accurate dosing. Liquid medications are absorbed more quickly than solid dosage forms, leading to a faster onset of action. This is especially important for medications used to treat acute conditions such as pain, nausea, and vomiting, thereby driving their demand. Advances in technology have led to the development of new formulations and packaging materials that improve the stability and shelf life of liquid medications. This has increased the demand for liquid dosage forms for medications that were previously only available in solid forms.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=268102519

Asia Pacific is expected to register the highest CAGR and also hold the largest share followed by Europe during the forecast period.

Japan is a well-established pharmaceutical product market due to its aging population and supportive government regulations, thereby attractive foreign investments for pharmaceutical manufacturing. The South Korean government has implemented initiatives to introduce medical coverage for four major chronic disease areas, including cancer, cardiovascular, cerebrovascular, and other rare diseases. Owing to these reasons, the country's pharmaceutical manufacturing infrastructure and research and development activities are growing Both the local and global demand for Chinese pharmaceutical manufacturing equipment is rising due to the availability of low-cost manufacturing facilities and quality assurance. Also, the outsourcing of manufacturing of pharmaceutical manufacturing operations to countries in Asia Pacific is a key factor driving the growth of the pharmaceutical manufacturing equipment industry in the region. In Europe, the presence of many major pharmaceutical companies, such as Pfizer, Abbott, GlaxoSmithKline, Sanofi, Boehringer Ingelheim, etc., are among the significant reasons boosting the growth of the pharmaceutical manufacturing industry in the region. the growing demand for branded and generic drugs across the region is catapulting the need for increasing production capacity and efficiency.

The report profiles key players in pharmaceutical manufacturing equipment companies such as GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US), Körber AG (Germany), Romaco Group (Germany), Marchesini Group (Italy), MG2 s.r.l. (Italy), and Glatt GmbH (Germany).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=268102519

Browse Adjacent Market: Semiconductor and Electronics Market Research Reports &Consulting

Related Reports:

Semiconductor Manufacturing Equipment Market by Front-end Equipment, Back-end Equipment, Fab Facility Equipment (Automation, Chemical Control, Gas Control), Product Type, Dimension, Supply Chain Participant and Region - Global Forecast to 2028

Industrial Agitators Market by Model Type (Large Tank, Portable, Drum, Pail, Tote), Mounting (Top, Side, Bottom Mounted), Component (Head, Impeller, Seal, Propeller, Turbines, Disperser), Form (Solid-Solid, Liquid-Gas), Region - Global Forecast to 2028

Photolithography Equipment Market by Type (EUV, DUV), Light Source (Mercury Lamps, Excimer Lasers, Fluorine Lasers, Laser-Produced Plasma), Wavelength, End User and Geography - Global Forecast to 2025

Industrial Metrology Market by Offering, Equipment, Application (Quality Control & Inspection, Reverse Engineering, Mapping & Modeling), End-User Industry (Aerospace & Defense, Automotive, Manufacturing, Semiconductor), Region - Global Forecast to 2027

HVAC System Market by Cooling Equipment (Unitary Air Conditioners, VRF Systems), Heating Equipment (Heat Pumps, Furnaces), Ventilation Equipment (AHUs, Air Filters), Implementation Type, Application and Region - Global Forecast to 2028

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact: Mr. Aashish MehraMarketsandMarkets™ INC. 630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected]Visit Our Web Site: https://www.marketsandmarkets.com/Research Insight: https://www.marketsandmarkets.com/ResearchInsight/pharmaceutical-manufacturing-equipment-market.aspContent Source: https://www.marketsandmarkets.com/PressReleases/pharmaceutical-manufacturing-equipment.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

SOURCE MarketsandMarkets

MarketsandMarkets